Attached files
| file | filename |
|---|---|
| 10-K/A - FORM 10-K/A - UROPLASTY INC | c58445ae10vkza.htm |
| EX-31.1 - EX-31.1 - UROPLASTY INC | c58445aexv31w1.htm |
| EX-31.2 - EX-31.2 - UROPLASTY INC | c58445aexv31w2.htm |
| EX-32.2 - EX-32.2 - UROPLASTY INC | c58445aexv32w2.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Uroplasty, Inc. (the “Company”) on Form 10-K for the year
ended March 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the
“Report”), I, David B. Kaysen, President and Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and
(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and result of operations of the Company.
June 18, 2010
| By | /s/ David B. Kaysen | |||
| David B. Kaysen | ||||
| President and Chief Executive Officer | ||||